Início › Câncer de Mama › Califórnia › Mountain View
Ensaios clínicos de Câncer de Mama em Mountain View, CA
26 estudos para Câncer de Mama estão buscando participantes em locais em Mountain View e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
RecrutandoFase 3
- Stanford Women's Cancer Center, Palo Alto · a 5 mi de distância
A Study of PHST001 in Advanced Solid Tumors
RecrutandoFase 1
- Stanford University School of Medicine, Palo Alto · a 5 mi de distância
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
RecrutandoFase 3
- El Camino Hospital, Mountain View
- Palo Alto Medical Foundation, Mountain View
A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer
RecrutandoFase 1/2
- Stanford Medicine Cancer Center, Stanford · a 5 mi de distância
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
RecrutandoFase 3
- El Camino Hospital Cancer Center ( Site 0096), Mountain View
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
RecrutandoFase 1
- Stanford University Medical Center, Stanford · a 5 mi de distância
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
RecrutandoFase 1
- Stanford University Medical Center, Stanford · a 5 mi de distância
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
RecrutandoFase 3
- Stanford Cancer Center, Palo Alto · a 5 mi de distância
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
RecrutandoFase 3
- Stanford University School of Medicine - Stanford Cancer Institute (SCI) - Stanford Women's Cancer Center, Palo Alto · a 5 mi de distância
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
RecrutandoFase 3
- Stanford Women's Cancer Center, Palo Alto · a 5 mi de distância
A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors
RecrutandoFase 1
- Stanford University Hospital, Stanford · a 5 mi de distância
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
RecrutandoFase 3
- Research Site, Palo Alto · a 5 mi de distância
A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer
RecrutandoFase 2
- Stanford Cancer Institute, Palo Alto · a 5 mi de distância
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
RecrutandoFase 3
- Palo Alto Medical Foundation Research Center, Palo Alto · a 5 mi de distância
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RecrutandoFase 3
- Palo Alto Medical Foundation-Camino Division, Mountain View
- Palo Alto Medical Foundation-Gynecologic Oncology, Mountain View
- Palo Alto Medical Foundation Health Care, Palo Alto · a 5 mi de distância
- e mais 1
Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast Cancer
RecrutandoFase 2
- Stanford University, Stanford · a 5 mi de distância
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
RecrutandoFase 2/3
- Local Institution - 0358, Stanford · a 5 mi de distância
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
RecrutandoFase 3
- Stanford Medicine Cancer Center - Stanford Women's Cancer Center, Palo Alto · a 5 mi de distância
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
RecrutandoFase 1
- Stanford University Medical Center, Palo Alto · a 5 mi de distância
Magnetic Resonance Imaging of Breast Cancer
RecrutandoVoluntários saudáveis bem-vindos
- Stanford University School of Medicine, Stanford · a 5 mi de distância
Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples
RecrutandoEstudo observacional
- Stanford University School of Medicine, Stanford · a 5 mi de distância
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
RecrutandoFase 3
- Palo Alto Medical Foundation-Camino Division, Mountain View
- Palo Alto Medical Foundation Health Care, Palo Alto · a 5 mi de distância
- Stanford Cancer Institute Palo Alto, Palo Alto · a 5 mi de distância
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
RecrutandoFase 1
- Stanford Cancer Institute, Stanford · a 5 mi de distância
Surgical Excision vs Neoadjuvant Radiotherapy+Delayed Surgical Excision of Ductal Carcinoma
Recrutando
- Stanford University, Stanford · a 5 mi de distância
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
RecrutandoEstudo observacional
- Stanford Cancer Institute, Palo Alto · a 5 mi de distância
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecrutandoEstudo observacional
- Massive Bio SYNERGY-AI site, Stanford · a 5 mi de distância
Ensaios de Câncer de Mama em outras cidades
- New York City, NY136 estudos
- Houston, TX126 estudos
- Boston, MA112 estudos
- Nashville, TN81 estudos
- Los Angeles, CA73 estudos
- Edison, NJ68 estudos
- St. Louis, MO64 estudos
- Queens, NY64 estudos
- Durham, NC64 estudos
- Chicago, IL59 estudos
- Philadelphia, PA56 estudos
- Dallas, TX55 estudos
Outros estudos em Mountain View
- Câncer (todos os tipos)40 estudos
- Câncer Metastático25 estudos
- Câncer de Pulmão de Não Pequenas Células21 estudos
- Leucemia Mieloide Aguda19 estudos
- Câncer de Ovário19 estudos
- Transtorno do Espectro Autista17 estudos
- Câncer de Pulmão17 estudos
- Câncer de Próstata15 estudos
- Insuficiência Cardíaca15 estudos
- Autismo13 estudos
- Leucemia Linfoblástica Aguda13 estudos
- Câncer Colorretal13 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.